Cheaper insulin may work just as well for youth with diabetes in poor regions
NCT ID NCT05614089
First seen Nov 01, 2025 · Last updated May 10, 2026 · Updated 28 times
Summary
This study tested whether a newer insulin (glargine) is safer and better at controlling blood sugar than older human insulin in young people aged 7-25 with type 1 diabetes living in low-resource settings. 400 participants were randomly assigned to receive either glargine or standard human insulin. The main goals were to see if glargine reduced dangerous low blood sugar episodes and improved time in the target blood sugar range over 6 months.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TYPE 1 DIABETES are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
BIRDEM Hospital
Dhaka, Bangladesh
-
Bugando Medical Center
Mwanza, Tanzania
-
Sekou-Toure Hospital
Mwanza, Tanzania
Conditions
Explore the condition pages connected to this study.